High-Purity Bioactive Catalog & Formulations
Explore verified food additives, amino acids, and high-potency health supplement actives shipped globally with lot-specific Certificate of Analysis (COA).
Biological Profile of Limosilactobacillus reuteri
A heterofermentative, Gram-positive probiotic strain reclassified from Lactobacillus reuteri, noted for indigenous colonization of the mammalian gastrointestinal, urogenital, and oral tracts.
Endogenous Reuterin Synthesis
L. reuteri uniquely converts glycerol via the enzymatic pathway mediated by glycerol dehydratase into 3-hydroxypropionaldehyde (3-HPA), known as reuterin. This broad-spectrum non-proteinaceous antimicrobial agent selectively suppresses Gram-negative enteric pathogens, yeasts, and protozoa without destabilizing commensal lactic acid bacteria populations.
- Suppresses Helicobacter pylori and Salmonella enterica
- Inhibits Candida albicans biofilm proliferation
- Thermostable metabolite with active gut-lumen persistence
Epithelial Adhesion Kinetics
Engineered with high surface hydrophobicity and specialized mucus-binding proteins (Mub), our bulk strain exhibits robust cellular adherence to human enterocyte cell lines (Caco-2 and HT-29). This competitive exclusion mechanism creates a dense mucosal protective barrier that resists physiological intestinal peristalsis.
- Specific mucus-binding protein (Mub) expression confirmed
- Strengthens tight junction claudin-1 and occludin complexes
- Reduces pathogen translocation across gut barrier
Immunomodulatory Signaling
Through interaction with dendritic cells via Toll-Like Receptors (TLR2), L. reuteri selectively stimulates anti-inflammatory cytokine production (IL-10) while suppressing pro-inflammatory cascades (TNF-α, IL-8). It also contributes to gut endocrine signaling via tryptophan catabolism into indole-3-aldehyde (IAld).
- Activates aryl hydrocarbon receptors (AhR) for barrier repair
- Increases secretory Immunoglobulin A (sIgA) secretion
- Reduces systemic low-grade endotoxemia markers
Industrial Bulk Specifications & Quality Parameters
Manufactured under ISO 22000, HACCP, and cGMP frameworks. Standardized to exact viable cell counts utilizing flow cytometry (ISO 19344) and plate count standards.
| Analytical Parameter | Commercial Grade 100B | Concentrate Grade 200B | Pharma/Ultra Grade 500B | Test Standard |
|---|---|---|---|---|
| Viable Cell Count (CFU/g) | ≥ 1.0 × 1011 | ≥ 2.0 × 1011 | ≥ 5.0 × 1011 | ISO 29981 / IDF 220 |
| Physical Appearance | Off-white to light yellow powder | Uniform free-flowing powder | Ultra-fine dry lyophilized powder | Visual / Organoleptic |
| Moisture Content (Karl Fischer) | ≤ 5.0% | ≤ 4.0% | ≤ 3.0% | USP ⟨921⟩ |
| Water Activity (aw at 25°C) | ≤ 0.15 | ≤ 0.12 | ≤ 0.10 | Chilled Mirror Dewpoint |
| Carrier Excipients | Maltodextrin / Trehalose | Prebiotic Inulin / FOS | Pharma Grade Trehalose Only | In-house Specification |
| Lead (Pb) / Arsenic (As) | ≤ 0.5 ppm / ≤ 0.5 ppm | ≤ 0.2 ppm / ≤ 0.2 ppm | ≤ 0.1 ppm / ≤ 0.1 ppm | ICP-MS (USP ⟨233⟩) |
| Pathogenic Microorganisms | Absence / 25g | Absence / 25g | Absence / 25g | FDA BAM Ch. 4, 10, 14 |
| Recommended Storage | -18°C or ≤ 4°C dry sealed | -18°C sealed foil pouches | -20°C deep freeze condition | Accelerated Stability Protocol |
China Factory Strategic & Technological Advantages
Located in the Qinling biotechnology corridor in Xi'an, Shaanxi, our fermentation plant delivers significant production economies, proprietary microencapsulation, and stable raw material traceability.
Ultra-High-Density Fermentation
Utilizing automated fed-batch bioreactors scaled up to 50,000-liter capacity, our process operates under continuous dissolved oxygen, pH, and nutrient-gradient monitoring. By optimizing bio-available nitrogen and micronutrient feeding, our biomass concentration reaches densities 3.5× higher than standard domestic lines, reducing energy consumption and lowering cost per billion CFU.
Dual-Layer Cryoprotection Lyophilization
Freeze-drying live cultures without cell membrane lysis requires precise glass transition temperature control. Our proprietary vacuum sublimation process employs a dual-layer natural carbohydrate matrix (trehalose + peptide envelope). This prevents intracellular ice recrystallization, ensuring post-drying survival rates > 92% and long-term shelf stability at ambient transit temperatures.
End-to-End Vertical Integration
From the seed-banking cryo-vials authenticated by Chinese microbial culture repositories to in-house upstream substrate preparation, downstream spray drying, milling, and nitrogen-purged packaging, zero critical production stages are subcontracted. This delivers complete lot-level batch transparency, audit readiness, and immune security against geopolitical raw material shocks.
Global Industry Trends in Limosilactobacillus reuteri
Transitioning from generic digestive blends to targeted microbiome therapeutics, postbiotic derivatives, and functional food integration.
1. Proliferation of Postbiotics and Paraprobiotics
Heat-killed (tyndallized) L. reuteri and cell-free supernatants containing intact peptidoglycans, exopolysaccharides, and lipoteichoic acids are experiencing exponential market demand. Postbiotic preparations completely bypass the cold-chain constraints of live cultures, allowing incorporation into thermal beverages, carbonated functional waters, baked nutrition bars, and extended-shelf-life topical cosmetics without loss of bioactivity.
2. Expansion into Live Biotherapeutic Products (LBPs)
Regulatory frameworks in North America (FDA IND pathways) and Europe (EMA guidelines) are establishing rigorous quality requirements for single-strain probiotics intended for medical foods and adjunct drug delivery. This trend mandates single-nucleotide polymorphism (SNP) genomic mapping, demonstrated absence of plasmid-borne antibiotic resistance genes, and validated clinical endpoints for indication-specific formulations.
3. Pediatric & Infant Gut-Immune Specialization
Clinical meta-analyses confirming L. reuteri efficacy in mitigating infantile colic, daily crying duration, and functional regurgitation have made it the gold-standard probiotic ingredient in pediatric oily drop formulations. Brand owners require low-moisture oil-suspension powder grades engineered to resist settling and maintain stable CFUs throughout multi-dose dropper bottle dispensing.
4. Animal Health & Antibiotic Replacement Mandates
Global phase-outs of prophylactic veterinary antibiotics have created an urgent need for agricultural-grade L. reuteri in swine and broiler poultry farming. Strains capable of producing high titers of reuterin suppress intestinal Clostridium perfringens and enterotoxigenic Escherichia coli (ETEC), driving feed-conversion efficiency without creating antimicrobial resistance.
Commercial Application Scenarios & Formulation Engineering
Comprehensive dosing guidelines, delivery vehicle matrices, and active ingredient synergies across diverse market segments.
Infant Colic & Gut Oil Drops
Target Concentration: 1 × 108 to 1 × 109 CFU/day in medium-chain triglyceride (MCT) or sunflower oil base.
Formulation Challenge: Maintaining suspension stability without phase separation or moisture ingress that triggers premature bacterial activation and cell death.
ShineHerb Solution: Lipophilic, micronized, dehydrated powder grade with anti-agglomeration characteristics optimized for liquid dropper filling lines.
Oral Health & Periodontal Lozenges
Target Concentration: 2 × 108 CFU/lozenge combined with xylitol, peppermint, and zinc citrate.
Mechanism: Competitively adheres to salivary pellicles, displacing Streptococcus mutans and Porphyromonas gingivalis. Reduces volatile sulfur compounds (VSC) that cause halitosis.
Tableting Note: Requires low-compression direct-compression binders (isomalt) to prevent mechanical pressure-induced bacterial cell wall shearing.
Women's Urogenital Flora Capsules
Synergistic Consortium: L. reuteri co-formulated with Lactobacillus rhamnosus and cranberry proanthocyanidins.
Pharmacological Action: Produces lactic acid and hydrogen peroxide to maintain an acidic vaginal pH (≤ 4.5), reducing recurrence of bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC).
Encapsulation: Packaged in delayed-release hypromellose (DRcaps) or enteric acid-resistant vegetable polymers.
Cardiometabolic & Cholesterol Support
Active Target: Bile Salt Hydrolase (BSH) active strains delivering 5 × 109 CFU per serving.
Clinical Endpoint: Deconjugates conjugated bile acids in the intestinal lumen, leading to fecal bile excretion. This prompts hepatic uptake of circulating LDL-cholesterol for de novo bile acid synthesis.
Synergies: Frequently blended with Phytosterols, Red Yeast Rice extract, or Coenzyme Q10 in cardiovascular softgels and sachets.
Dermatological Skincare & Cosmeceuticals
Form: Tyndallized Postbiotic Lysate (INCI: Lactobacillus Ferment Lysate) or living microencapsulated beads.
Dermal Action: Modulates skin commensal microbiota, suppressing Cutibacterium acnes hypercolonization. Stimulates ceramide and filaggrin synthesis to repair compromised stratum corneum barriers.
Application: Calming facial serums, post-laser recovery creams, and microbiome-friendly scalp anti-dandruff solutions.
Veterinary Swine & Poultry Nutrition
Format: High-potency heat-resistant coated feed additive (5 × 1010 CFU/g).
Agronomic Impact: Reduces post-weaning diarrhea in piglets, decreases reliance on zinc oxide and colistin, improves intestinal villus height-to-crypt depth ratio, and promotes nitrogen absorption.
Pelleting Survival: Micro-encapsulated matrix designed to withstand feed-mill steam pelleting conditioning up to 75°C for 30 seconds.
End-to-End Cold-Chain Export & Packaging Engineering
Probiotic viability is highly sensitive to ambient humidity and temperature excursions during international transit. Our global logistics protocols safeguard live cell counts from factory gate to destination warehouse.
Tri-Layer Aluminum Foil Vacuum Barrier
Bulk powder is sealed in medical-grade, multi-laminate barrier bags (PET/Alu/PE) with a moisture vapor transmission rate (MVTR) < 0.005 g/m²/day and oxygen permeability < 0.05 cm³/m²/day. Each pouch undergoes high-purity nitrogen purge (> 99.9% N2 flush) to achieve residual headspace oxygen < 0.5%, arresting bacterial metabolic degradation.
Validated Temperature-Controlled Freight
Shipments are executed via dedicated reefer containers (-18°C maritime freight) or cold-chain express air transit featuring vacuum-insulated panels (VIP) and Phase Change Material (PCM) dry-ice gel blankets maintaining < -10°C for up to 120 hours. Every master carton incorporates a USB/NFC real-time data logger recording temperature and humidity at 10-minute intervals.
Regulatory Clearance & Customs Expediting
Our export documentation dossier includes custom tariff declarations (HS Code: 3002.90.0000 or 2106.90.9090), non-pathogenic veterinary health certificates, CITES non-endangered declarations, Shipper's Declaration for Dangerous Goods (Dry Ice exemption handling), and country-specific Certificate of Origin (Form E, Form A, RCEP).
Global Enterprise Sourcing & Supplier Audit Standards
Essential criteria utilized by procurement directors, quality assurance managers, and regulatory heads when qualifying a primary probiotic fermentation supplier.
Quality Dossier & Analytical Testing
Every industrial delivery is accompanied by comprehensive release documentation confirming analytical conformance:
- Batch-Specific Certificate of Analysis (COA): Validated CFU assay, loss on drying, heavy metal screen (Pb, Cd, As, Hg by ICP-MS), residual solvents.
- Strain Authenticity & Genetic Stability: 16S rRNA gene sequencing and pulsed-field gel electrophoresis (PFGE) strain identification reports.
- Antimicrobial Susceptibility Testing (AST): Minimum Inhibitory Concentration (MIC) profiles complying with EFSA (European Food Safety Authority) thresholds.
- Absence of Antibiotic Resistance Transferability: Whole genome analysis demonstrating lack of transmissible plasmid-borne resistance determinants.
Manufacturing Facility & Ethical Auditing
Shaanxi ShineHerb Biotech operates under international governance systems ready for on-site or digital third-party inspection:
- Current Good Manufacturing Practice (cGMP): Class 100,000 cleanroom HVAC filtration, validated Clean-In-Place (CIP) systems for bioreactors.
- International Food Safety: Dual certification under FSSC 22000 (Version 5.1) and ISO 9001:2015 quality management.
- Dietary Inclusivity: Annual third-party audits for Halal (MUI/JAKIM compliant) and Kosher certification.
- Allergen Control Protocol: Dedicated milk-free, soy-free, and gluten-free line validation (ELISA pathogen swabbing).
Frequently Asked Questions for Probiotic Buyers
Direct technical and operational answers to support formulation feasibility, trial validation, and commercial procurement decisions.
What is the difference between standard Lactobacillus reuteri and Limosilactobacillus reuteri?
How does ShineHerb verify bacterial strain stability and prevent genetic drift during industrial scale-up?
What carrier excipients are utilized, and can custom non-allergenic carriers be specified?
What are the critical parameters for incorporating bulk L. reuteri into dry powder blends or capsules?
What sampling and testing protocols are recommended upon cargo receipt?
What is the Minimum Order Quantity (MOQ) and typical delivery lead time for export orders?
Complementary Cosmetic, Peptide & Food Grade Ingredients
Integrate certified functional ingredients, antioxidants, and cellular health actives from our Shaanxi manufacturing and extraction facilities.
